1 results match your criteria: "b Clinical Development and Medical Affairs[Affiliation]"
Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay.
Curr Med Res Opin
May 2017
b Clinical Development and Medical Affairs, Prometheus Laboratories Inc. , San Diego , CA , USA.
Objective: In 2013 a novel commercial test was launched (Anser ADA test) for the assay of serum adalimumab (ADL) and antibodies to adalimumab (ATA). This study aims to understand clinical practice patterns used with ADL in a real-world cross-sectional population.
Methods: Wilcoxon rank sum test, and linear and logistic regression methods were applied in the statistical analysis to test hypotheses.